Featured Research

from universities, journals, and other organizations

Treatment of Barrett's esophagus may lower risk of esophageal cancer

Date:
April 4, 2011
Source:
Northwestern Memorial Hospital
Summary:
Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans. New guidelines support use of radiofrequency ablation to remove precancerous cells.

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans. While traditionally managed through watchful waiting, experts at Northwestern Medicine's Center for Esophageal Disease have been among the pioneers of ablation treatment and have long seen the benefits of early treatment.

Frequent heartburn, regurgitation, and trouble swallowing are common symptoms of GERD (gastroesophageal reflux disease), which experts believe is the result of stomach contents washing back into the esophagus leading to the development of Barrett's Esophagus. Repeat exposure to stomach acids can result in damage to the esophagus and cause healthy cells to transform into these precancerous cells. Unfortunately, many patients with Barrett's Esophagus can be asymptomatic.

"The incidence of esophageal cancer is increasing more rapidly than any other type of cancer in the United States and survival rates remain low," said Northwestern Medicine gastroenterologist Srinadh Komanduri, MD. "Barrett's esophagus is a precancerous condition, and while the majority of people who suffer from the disorder will never develop cancer, the risk is present. Early treatment with RFA would likely reduce a patient's chance to develop cancer."

RFA burns away layers of abnormal cells and effectively eliminates the disease in 90-100 percent of patients. Doctors use a flexible tube (endoscopy) inserted into the esophagus to reach the treatment area, which also provides access for taking biopsies or endoscopic resection of suspicious lesions.

Northwestern's Center for Esophageal Disease is the top program in Chicago and has treated more than 130 patients with endoscopic therapy.

"We have seen great results using RFA therapy," said Komanduri who is also an assistant professor of medicine at Northwestern University Feinberg School of Medicine. "It effectively cures Barrett's esophagus in most patients, leads to fewer surgical procedures for the disease, and contributes to lowering the growth rate of esophageal cancer."

The new AGA guidelines recommend RFA treatment for patients with low to high grade dysplasia due to Barrett's esophagus and suggest it as an effective option for high-risk patients without dysplasia. Speak with your physician to determine if you are a candidate.


Story Source:

The above story is based on materials provided by Northwestern Memorial Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern Memorial Hospital. "Treatment of Barrett's esophagus may lower risk of esophageal cancer." ScienceDaily. ScienceDaily, 4 April 2011. <www.sciencedaily.com/releases/2011/04/110404111052.htm>.
Northwestern Memorial Hospital. (2011, April 4). Treatment of Barrett's esophagus may lower risk of esophageal cancer. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2011/04/110404111052.htm
Northwestern Memorial Hospital. "Treatment of Barrett's esophagus may lower risk of esophageal cancer." ScienceDaily. www.sciencedaily.com/releases/2011/04/110404111052.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins